Pharmacology

Acute coronary syndromes

Net clinical benefit of bivalirudin in STEMI patients

Original title: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous...

solaci - 29 January, 2015

Learn More

Antithrombotic Anticoagulants

Never ending controversy over the duration of post DES dual antiplatelet therapy

Original title: Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy- The SECURITY...

solaci - 15 January, 2015

Learn More

Antithrombotic Anticoagulants

Risks and benefits of Dual Antiplatelet beyond the year of a drug-eluting stent

Original title: Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents. Reference: Laura Mauri et al....

solaci - 13 January, 2015

Learn More

Acute coronary syndromes

Thienopyridine Pretreatment in Non ST Elevation ACS syndrome

Original title: Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and...

solaci - 16 December, 2014

Learn More

Antithrombotic Anticoagulants

Greater platelet reactivity in diabetic patients receiving DES and clopidogrel

Original title: Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients...

solaci - 20 October, 2014

Learn More

Antithrombotic Anticoagulants

Resistance to Aspirin Associated to Greater Risk of In-Stent Thrombosis and Death

Original title: Aspirin Treatment and Outcomes After Percutaneous Coronary InterventionResults of the ISAR-ASPI Registry. Reference: Katharina Mayer et al. J...

solaci - 29 August, 2014

Learn More

Antiplatelet

Less Bleeding at the Expense of a Higher Risk of Acute Thrombosis with Bivalirudin

Original title: Bivalirudin versus heparin in patients treated with percutaneous coronary Intervention: a meta-analysis of randomised trials. Reference: Salvatore Cassese...

solaci - 20 August, 2014

Learn More

Acute coronary syndromes

Best ejection fraction using Metoprolol as pretreatment in acute myocardial infarction

Original title: Long-Term Benefict of Early Pre-Reperfusion Metoprolol Administraction in Patients With Acute Myocardial Infaction. From the METOCARD-CNIC...

solaci - 25 June, 2014

Learn More

Net clinical benefit of bivalirudin in STEMI patients

Never ending controversy over the duration of post DES dual antiplatelet therapy

Risks and benefits of Dual Antiplatelet beyond the year of a drug-eluting stent

Thienopyridine Pretreatment in Non ST Elevation ACS syndrome

Greater platelet reactivity in diabetic patients receiving DES and clopidogrel

Resistance to Aspirin Associated to Greater Risk of In-Stent Thrombosis and Death

Less Bleeding at the Expense of a Higher Risk of Acute Thrombosis with Bivalirudin

Best ejection fraction using Metoprolol as pretreatment in acute myocardial infarction

Last News

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Institutional News

SOLACI Wishes You Happy Holidays

Condolences on the passing of Cristiam Arancibia

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Access